Compile Data Set for Download or QSAR
Report error Found 491 Enz. Inhib. hit(s) with all data for entry = 10915
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577937(US11478460, Compound 1.277)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577935(US11478460, Compound 1.275)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577936(US11478460, Compound 1.276)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577941(US11478460, Compound 1.281)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577948(US11478460, Compound 1.288)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577922(US11478460, Compound 1.262)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577929(US11478460, Compound 1.269)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577930(US11478460, Compound 1.270)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577934(US11478460, Compound 1.274)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577932(US11478460, Compound 1.272)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577969(US11478460, Compound 1.309)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577968(US11478460, Compound 1.308)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577972(US11478460, Compound 1.312)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577977(US11478460, Compound 1.317)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577978(US11478460, Compound 1.318)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577975(US11478460, Compound 1.315)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577976(US11478460, Compound 1.316)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577981(US11478460, Compound 1.321)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577982(US11478460, Compound 1.322)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577979(US11478460, Compound 1.319)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577980(US11478460, Compound 1.320)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577956(US11478460, Compound 1.296)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577959(US11478460, Compound 1.299)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577960(US11478460, Compound 1.300)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577963(US11478460, Compound 1.303 | US11478460, Compound ...)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM578002(US11478460, Compound 1.342)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577999(US11478460, Compound 1.339)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM578005(US11478460, Compound 1.345)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM578003(US11478460, Compound 1.343)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM578004(US11478460, Compound 1.344)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM578007(US11478460, Compound 1.347)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM578011(US11478460, Compound 1.351)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577985(US11478460, Compound 1.325)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577986(US11478460, Compound 1.326)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577983(US11478460, Compound 1.323)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577984(US11478460, Compound 1.324)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577989(US11478460, Compound 1.329)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577990(US11478460, Compound 1.330 | US11478460, Compound ...)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577987(US11478460, Compound 1.327)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577988(US11478460, Compound 1.328)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577993(US11478460, Compound 1.333)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577994(US11478460, Compound 1.334)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577990(US11478460, Compound 1.330 | US11478460, Compound ...)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577992(US11478460, Compound 1.332)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM577995(US11478460, Compound 1.335)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM578017(US11478460, Compound 1.357)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM578018(US11478460, Compound 1.358)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM578021(US11478460, Compound 1.361)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM578022(US11478460, Compound 1.362)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Chemocentryx

US Patent
LigandPNGBDBM578019(US11478460, Compound 1.359)
Affinity DataIC50: 5nMAssay Description:Optionally, compounds may be further assayed for their ability to inhibit chemotaxis in cells. Chemotaxis assays are performed using 5 μm pore p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/30/2022
Entry Details
US Patent

Displayed 1 to 50 (of 491 total ) | Next | Last >>
Jump to: